These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10788519)

  • 1. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion.
    Galliano MF; Huet C; Frygelius J; Polgren A; Wewer UM; Engvall E
    J Biol Chem; 2000 May; 275(18):13933-9. PubMed ID: 10788519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloprotease-disintegrin ADAM 12 interacts with alpha-actinin-1.
    Cao Y; Kang Q; Zolkiewska A
    Biochem J; 2001 Jul; 357(Pt 2):353-61. PubMed ID: 11439084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of metalloprotease disintegrin ADAM12 in determination of quiescent reserve cells during myogenic differentiation in vitro.
    Cao Y; Zhao Z; Gruszczynska-Biegala J; Zolkiewska A
    Mol Cell Biol; 2003 Oct; 23(19):6725-38. PubMed ID: 12972593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloprotease-disintegrin ADAM 12 binds to the SH3 domain of Src and activates Src tyrosine kinase in C2C12 cells.
    Kang Q; Cao Y; Zolkiewska A
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):883-92. PubMed ID: 11104699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the disintegrin and cysteine-rich domains of ADAM12 with integrin alpha7beta1.
    Zhao Z; Gruszczynska-Biegala J; Cheuvront T; Yi H; von der Mark H; von der Mark K; Kaufman SJ; Zolkiewska A
    Exp Cell Res; 2004 Aug; 298(1):28-37. PubMed ID: 15242759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation.
    Lafuste P; Sonnet C; Chazaud B; Dreyfus PA; Gherardi RK; Wewer UM; Authier FJ
    Mol Biol Cell; 2005 Feb; 16(2):861-70. PubMed ID: 15574885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
    J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disintegrin-like/cysteine-rich region of ADAM 12 is an active cell adhesion domain.
    Zolkiewska A
    Exp Cell Res; 1999 Nov; 252(2):423-31. PubMed ID: 10527632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells.
    Kang Q; Cao Y; Zolkiewska A
    J Biol Chem; 2001 Jul; 276(27):24466-72. PubMed ID: 11313349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of ADAM12 (meltrin alpha) in human giant cell tumours of bone.
    Tian BL; Wen JM; Zhang M; Xie D; Xu RB; Luo CJ
    Mol Pathol; 2002 Dec; 55(6):394-7. PubMed ID: 12456779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metalloprotease-disintegrin participating in myoblast fusion.
    Yagami-Hiromasa T; Sato T; Kurisaki T; Kamijo K; Nabeshima Y; Fujisawa-Sehara A
    Nature; 1995 Oct; 377(6550):652-6. PubMed ID: 7566181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function.
    Kawaguchi N; Sundberg C; Kveiborg M; Moghadaszadeh B; Asmar M; Dietrich N; Thodeti CK; Nielsen FC; Möller P; Mercurio AM; Albrechtsen R; Wewer UM
    J Cell Sci; 2003 Oct; 116(Pt 19):3893-904. PubMed ID: 12915587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular processing of metalloprotease disintegrin ADAM12.
    Cao Y; Kang Q; Zhao Z; Zolkiewska A
    J Biol Chem; 2002 Jul; 277(29):26403-11. PubMed ID: 12000744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.
    Yi H; Gruszczynska-Biegala J; Wood D; Zhao Z; Zolkiewska A
    J Biol Chem; 2005 Jun; 280(25):23475-83. PubMed ID: 15849365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands.
    Tanaka M; Nanba D; Mori S; Shiba F; Ishiguro H; Yoshino K; Matsuura N; Higashiyama S
    J Biol Chem; 2004 Oct; 279(40):41950-9. PubMed ID: 15280379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins.
    Moghadaszadeh B; Albrechtsen R; Guo LT; Zaik M; Kawaguchi N; Borup RH; Kronqvist P; Schroder HD; Davies KE; Voit T; Nielsen FC; Engvall E; Wewer UM
    Hum Mol Genet; 2003 Oct; 12(19):2467-79. PubMed ID: 12915458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction.
    Eto K; Puzon-McLaughlin W; Sheppard D; Sehara-Fujisawa A; Zhang XP; Takada Y
    J Biol Chem; 2000 Nov; 275(45):34922-30. PubMed ID: 10944520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
    Shi Z; Xu W; Loechel F; Wewer UM; Murphy LJ
    J Biol Chem; 2000 Jun; 275(24):18574-80. PubMed ID: 10849447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells.
    Inoue D; Reid M; Lum L; Krätzschmar J; Weskamp G; Myung YM; Baron R; Blobel CP
    J Biol Chem; 1998 Feb; 273(7):4180-7. PubMed ID: 9461614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLRG, a new ADAM12-associated protein, modulates osteoclast differentiation.
    Bartholin L; Destaing O; Forissier S; Martel S; Maguer-Satta V; Jurdic P; Rimokh R
    Biol Cell; 2005 Jul; 97(7):577-88. PubMed ID: 15574124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.